ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$22.76
+2.06%
Mkt Cap $3.74B
Analyst Ratings
Buy
13
Hold
3
Sell
0
Price Target (60 analysts)
$34.78
Range $29.00 – $40.00
Implied Upside
+52.8%
Consensus $34.78 vs current $22.76
NASDAQ·Healthcare·Biotechnology
$22.76
+2.06%
Mkt Cap $3.74B
Buy
13
Hold
3
Sell
0
Price Target (60 analysts)
$34.78
Range $29.00 – $40.00
+52.8%
Consensus $34.78 vs current $22.76